Zhuozhi Dai1,2, Sanjay Kalra3, Dennell Mah3, Peter Seres2, Hongfu Sun4, Renhua Wu5, Alan H Wilman6. 1. Department of Radiology, 2nd Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, China. 2. Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, T6G 2V2, Canada. 3. Department of Medicine (Neurology), University of Alberta, Edmonton, Alberta, T6G 2S2, Canada. 4. School of Information Technology and Electrical Engineering, University of Queensland, Brisbane, Queensland, 4072, Australia. 5. Department of Radiology, 2nd Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, China. rhwu@stu.edu.cn. 6. Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, T6G 2V2, Canada. wilman@ualberta.ca.
Abstract
OBJECTIVES: The aim of the study is to assess amide concentration changes in ALS patients compared with healthy controls by using quantitative amide proton transfer (APT) and multiparameter magnetic resonance imaging, and testing its correlation with clinical scores. METHODS: Sixteen ALS patients and sixteen healthy controls were recruited as part of the Canadian ALS Neuroimaging Consortium, and multimodal magnetic resonance imaging was performed at 3 T, including APT and diffusion imaging. Lorentz fitting was used to quantify the amide effect. Clinical disability was evaluated using the revised ALS functional rating scale (ALSFRS-R), and its correlation with image characteristics was assessed. The diagnostic performance of different imaging parameters was evaluated with receiver operating characteristic analysis. RESULTS: Our results showed that the amide peak was significantly different between the motor cortex and other gray matter territories within the brain of ALS patients (p < 0.001). Compared with controls, amide signal intensities in ALS were significantly reduced in the motor cortex (p < 0.001) and corticospinal tract (p = 0.046), while abnormalities were not detected using routine imaging methods. There was no significant correlation between amide and ALSFRS-R score. The diagnostic accuracy of the amide peak was superior to that of diffusion imaging. CONCLUSIONS: This study demonstrated changes of amide signal intensities in the motor cortex and corticospinal tract of ALS patients. KEY POINTS: • The neurodegenerative disease amyotrophic lateral sclerosis (ALS) has a lack of objective imaging indicators for diagnosis and assessment. • Analysis of amide proton transfer imaging revealed changes in the motor cortex and corticospinal tract of ALS patients that were not visible on standard magnetic resonance imaging. • The diagnostic accuracy of the amide peak was superior to that of diffusion imaging.
OBJECTIVES: The aim of the study is to assess amide concentration changes in ALSpatients compared with healthy controls by using quantitative amide proton transfer (APT) and multiparameter magnetic resonance imaging, and testing its correlation with clinical scores. METHODS: Sixteen ALSpatients and sixteen healthy controls were recruited as part of the Canadian ALS Neuroimaging Consortium, and multimodal magnetic resonance imaging was performed at 3 T, including APT and diffusion imaging. Lorentz fitting was used to quantify the amide effect. Clinical disability was evaluated using the revised ALS functional rating scale (ALSFRS-R), and its correlation with image characteristics was assessed. The diagnostic performance of different imaging parameters was evaluated with receiver operating characteristic analysis. RESULTS: Our results showed that the amide peak was significantly different between the motor cortex and other gray matter territories within the brain of ALSpatients (p < 0.001). Compared with controls, amide signal intensities in ALS were significantly reduced in the motor cortex (p < 0.001) and corticospinal tract (p = 0.046), while abnormalities were not detected using routine imaging methods. There was no significant correlation between amide and ALSFRS-R score. The diagnostic accuracy of the amide peak was superior to that of diffusion imaging. CONCLUSIONS: This study demonstrated changes of amide signal intensities in the motor cortex and corticospinal tract of ALSpatients. KEY POINTS: • The neurodegenerative disease amyotrophic lateral sclerosis (ALS) has a lack of objective imaging indicators for diagnosis and assessment. • Analysis of amide proton transfer imaging revealed changes in the motor cortex and corticospinal tract of ALSpatients that were not visible on standard magnetic resonance imaging. • The diagnostic accuracy of the amide peak was superior to that of diffusion imaging.
Entities:
Keywords:
Amyotrophic lateral sclerosis; Brain; Magnetic resonance imaging
Authors: Matthew C Kiernan; Steve Vucic; Benjamin C Cheah; Martin R Turner; Andrew Eisen; Orla Hardiman; James R Burrell; Margaret C Zoing Journal: Lancet Date: 2011-02-04 Impact factor: 79.321
Authors: Alex McCampbell; Tracy Cole; Amy J Wegener; Giulio S Tomassy; Amy Setnicka; Brandon J Farley; Kathleen M Schoch; Mariah L Hoye; Mark Shabsovich; Linhong Sun; Yi Luo; Mingdi Zhang; Nicole Comfort; Bin Wang; Jessica Amacker; Sai Thankamony; David W Salzman; Merit Cudkowicz; Danielle L Graham; C Frank Bennett; Holly B Kordasiewicz; Eric E Swayze; Timothy M Miller Journal: J Clin Invest Date: 2018-07-16 Impact factor: 14.808
Authors: Neil G Simon; Martin R Turner; Steve Vucic; Ammar Al-Chalabi; Jeremy Shefner; Catherine Lomen-Hoerth; Matthew C Kiernan Journal: Ann Neurol Date: 2014-09-30 Impact factor: 10.422